Johnathan Ebben MD, PhD Profile picture
Physician-scientist. Aspiring therapeutics developer. Turning basic science into medicine.

Feb 16, 2023, 14 tweets

@TumorBoardTues @arkhaki @glovedoc @PGrivasMDPhD @rafee_talukder @MPishvaian @Uromigos 2/5 #TumorBoardTuesday
Case🎀

Take🏠
✅For plat ineligible, pembro=1L option
✅4 cycles of plat tx ➡️ IO maint equally efficacious to 6 cycles
✅Early prog predicts⬇️2L IO benefit
✅💔Myocarditis irAE needs aggressive mgmt

📚@arkhaki @glovedoc’s thread
threadreaderapp.com/thread/1625661…

@TumorBoardTues @arkhaki @glovedoc @PGrivasMDPhD @rafee_talukder @MPishvaian @Uromigos 3/5 #TumorBoardTuesday
Thurs Case🎀

🎥 TBT in video
Pembro= 1L option for pts not eligible for plat tx.
☑️4 cycles plat doublet AS GOOD as 6 in plat eligible
💔ICI myocarditis is rare, but serious- we discuss tx

Quick video summary covering major pts in just over 2 mins!

@TumorBoardTues @arkhaki @glovedoc @PGrivasMDPhD @rafee_talukder @MPishvaian @Uromigos 4/5 #TumorBoardTuesday
Thurs Case🎀

📷 TBT in an image: Quick overview of tx options in advanced #urothelialcarcinoma.

For patients that DO receive platinum tx, initial response is predictive of IO efficacy in the 2L setting.

@TumorBoardTues @arkhaki @glovedoc @PGrivasMDPhD @rafee_talukder @MPishvaian @Uromigos @ParamMD @UroOnc @vinay_onc @brian_rini @MichaelStaehler @DrChoueiri @dawood_findakly 5/5 #TumorBoardTuesday
Thursday Case🎀

🙏IO offers option to pts not able to receive platinum tx to treat #urothelialcarcinoma
🤔Awaiting data on ADC + IO combos

➡️Join us on 02/21/2023: @NarjustFlorezMD @ShrutiPatelMD present a case of
I/O + chemo #LCSM #LungCancer 😀

@TumorBoardTues @arkhaki @glovedoc @PGrivasMDPhD @rafee_talukder @MPishvaian @Uromigos @ParamMD @UroOnc @vinay_onc @brian_rini @MichaelStaehler @DrChoueiri @dawood_findakly @NarjustFlorezMD @ShrutiPatelMD Are you a fellow? Do you enjoy #TumorBoardTuesday?

Fill out our BRIEF survey (less than 2 mins)- we can pair you up w leading faculty from around the world to present a TBT case!

Great for your CV, networking & to learn in an ever-changing field!

@TumorBoardTues @arkhaki @glovedoc @PGrivasMDPhD @rafee_talukder @MPishvaian @Uromigos @ParamMD @UroOnc @vinay_onc @brian_rini @MichaelStaehler @DrChoueiri @dawood_findakly @NarjustFlorezMD @ShrutiPatelMD Remember #TumorBoardTuesday continues to offer AMA & MOC credit for FREE! Don’t forget to answer the polls👇🏽
Then click this link to quickly request your credit!
CME eval🔗: integrityce.com/tbteval
ALL CME 🔗: integrityce.com/tbt

Share this Scrolly Tale with your friends.

A Scrolly Tale is a new way to read Twitter threads with a more visually immersive experience.
Discover more beautiful Scrolly Tales like this.

Keep scrolling